Ausgabe 1/2022
Inhalt (19 Artikel)
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review
Edith A. Perez, Chau Dang, Caleb Lee, Jasmeet Singh, Kongming Wang, J. Bradley Layton, Alicia Gilsenan, Michelle D. Hackshaw, Javier Cortes
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis
Alexandra Giatromanolaki, Anastasia G. Gkegka, Stamatia Pouliliou, Eirini Biziota, Stylianos Kakolyris, Michael Koukourakis
Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients
Elizabeth Lerner Papautsky, Martha Carlson, Sheila M. Johnson, Hannah Montague, Deanna J. Attai, Maryam B. Lustberg
Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer
Julia E. McGuinness, Vicky Ro, Simukayi Mutasa, Samuel Pan, Jianhua Hu, Meghna S. Trivedi, Melissa K. Accordino, Kevin Kalinsky, Dawn L. Hershman, Richard S. Ha, Katherine D. Crew
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study
Caroline Boman, Luisa Edman Kessler, Jonas Bergh, Alexios Matikas, Theodoros Foukakis
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer
Mario E. Lacouture, Shari B. Goldfarb, Alina Markova, Sant P. Chawla, Karan Dewnani, Marc Iacobucci, Julie E. Lang
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
Karen S. Anderson, Timothy K. Erick, Meixuan Chen, Heather Daley, Margaret Campbell, Yolonda Colson, Martin Mihm, Labib R. Zakka, Marika Hopper, William Barry, Eric P. Winer, Glenn Dranoff, Beth Overmoyer
Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE)
Bhavika K. Patel, Kay Pepin, Kathy R. Brandt, Gina L. Mazza, Barbara A. Pockaj, Jun Chen, Yuxiang Zhou, Donald W. Northfelt, Karen Anderson, Juliana M. Kling, Celine M. Vachon, Kristin R. Swanson, Mehdi Nikkhah, Richard Ehman
Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study
Doris M. Howell, Kelly Metcalfe, Shiying Kong, Joanne Stephen, Ivo A. Olivotto, Nancy Baxter, Christine M. Friedenreich, Ellen Warner, Mohammed Reza Akbari, Kristine McBain, Steven Narod, May Lynne Quan
Effect of estradiol as a continuous variable on breast cancer survival by menopausal status: a cohort study in China
Junxian Li, Chenyang Li, Ziwei Feng, Luyang Liu, Liwen Zhang, Wenjuan Kang, Ya Liu, Baoshan Ma, Haixin Li, Yubei Huang, Hong Zheng, Fangfang Song, Fengju Song, Kexin Chen
Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy
Brenna C. McDonald, Kathleen Van Dyk, Rachael L. Deardorff, Jessica N. Bailey, Wanting Zhai, Judith E. Carroll, James C. Root, Tim A. Ahles, Jeanne S. Mandelblatt, Andrew J. Saykin
Hypertensive diseases of pregnancy and risk of breast cancer in the Black Women’s Health Study
Zahna Bigham, Yvonne Robles, Karen M. Freund, Julie R. Palmer, Kimberly A. Bertrand
Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ
Melissa Anne Mallory, Karissa Whiting, Anna Park, Mithat Gönen, Elizabeth Gilbert, Tari A. King, Melissa L. Pilewskie
Serum hormone levels and normal breast histology among premenopausal women
Mark E. Sherman, Thomas de Bel, Michael G. Heckman, Launia J. White, Joshua Ogony, Melody Stallings-Mann, Tracy Hilton, Amy C. Degnim, Robert A. Vierkant, Tanya Hoskin, Matthew R. Jensen, Laura Pacheco-Spann, Jill E. Henry, Anna Maria Storniolo, Jodi M. Carter, Stacey J. Winham, Derek C. Radisky, Jeroen van der Laak
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study
Mark van Barele, Amy Rieborn, Bernadette A. M. Heemskerk-Gerritsen, Inge-Marie Obdeijn, Linetta B. Koppert, Claudette E. Loo, Rob A. E. M. Tollenaar, Margreet G. E. M. Ausems, Irma van de Beek, Lieke P. V. Berger, Maaike de Boer, Liselot P. van Hest, C. Marleen Kets, Matti Rookus, Marjanka K. Schmidt, Agnes Jager, Maartje J. Hooning
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer
Divya A. Parikh, Lisa Kody, Susie Brain, Diane Heditsian, Vivian Lee, Christina Curtis, Mardi R. Karin, Irene L. Wapnir, Manali I. Patel, George W. Sledge Jr, Jennifer L. Caswell-Jin
CBCRisk-Black: a personalized contralateral breast cancer risk prediction model for black women
Ibrahim Hossain Sajal, Marzana Chowdhury, Tingfang Wang, David Euhus, Pankaj K. Choudhary, Swati Biswas
Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region
Siham Chafai Elalaoui, Fatima Zohra Laarabi, Lamiae Afif, Jaber Lyahyai, Ilham Ratbi, Imane Cherkaoui Jaouad, Yassamine Doubaj, Meryem Sahli, Mouna Ouhenach, Abdelaziz sefiani
Axillary radiation alone is a suboptimal treatment for ypN + in patients with triple negative breast cancer and axillary lymph node dissection should be considered in this setting
Parinita Keshav Swarnkar, Kefah Mokbel